In pancreatic neuroendocrine tumors (PanNETs), ALT correlates with higher grade, metastatic disease, and reduced survival, reflecting the aggressive biology driven by ATRX/DAXX loss of function [7,8]. The gene discussed is GPT; the disease is pancreatic neuroendocrine tumor.